The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DREAMM-9 final analysis: Belantamab mafodotin (belamaf), bortezomib, lenalidomide, and dexamethasone (BVRd) for transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM).
 
Saad Usmani
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Genentech; GlaxoSmithKline; Janssen Oncology; Oricell Therapeutics; Regeneron
Research Funding - Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Gracell Therapeutics; Janssen Oncology; K36 Therapeutics
 
Michal Mielnik
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Lilly; MSD; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; GlaxoSmithKline; Janssen
 
Aránzazu Alonso
Honoraria - Abbvie; BeOne Medicines; GlaxoSmithKline; Incyte; Johnson & Johnson; Roche
 
Al-Ola Abdallah
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Sanofi (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - PSA vaccine patent
 
Mamta Garg
Employment - NHS England
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; CTI; GlaxoSmithKline; Janssen; Pfizer; Sanofi; Stemline Therapeutics
Speakers' Bureau - Amgen; AOP Orphan Pharmaceuticals; GlaxoSmithKline; Janssen; Novartis; Pfizer; Sanofi
 
Wojciech Janowski
Consulting or Advisory Role - AstraZeneca; Janssen
Speakers' Bureau - BeiGene
 
Youngil Koh
Stock and Other Ownership Interests - Curocell; NOBO medicine; PROTEINA
Honoraria - Celltrion
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Novartis; Takeda
Research Funding - Curocell
Patents, Royalties, Other Intellectual Property - Proteina
 
Enrique Ocio
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini; Oncopeptides; Pfizer; Regeneron; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Menarini; Oncopeptides; Pfizer; Regeneron; Sanofi; Takeda
Speakers' Bureau - Janssen-Cilag; Sanofi
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - BMS; GlaxoSmithKline; Johnson & Johnson/Janssen; Lilly; Pfizer; Sanofi
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Karthik Ramasamy
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Recordati; Takeda
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Menarini; Oncopeptides; Pfizer; Recordati; Stemline Therapeutics; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Recordati; Takeda
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Paula Rodríguez-Otero
Consulting or Advisory Role - Abbvie; AstraZeneca; BMS; GlaxoSmithKline; H3 Biomedicine; Johnson and Johnson; Menarini Steamline; Oncopeptides; Pfizer; Roche; Sanofi
Speakers' Bureau - Abbvie; BMS; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Johnson and Johnson; Menarini Steamline; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Irwindeep Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Forus; GlaxoSmithKline; Janssen; Kite/Gilead; Pfizer; Sanofi; Vertex
 
Katja Weisel
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Novartis; Oncopeptides; Pfizer; Regeneron; Roche; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; CellCentric; GlaxoSmithKline; Janssen-Cilag; Oncopeptides; Pfizer; Regeneron; Roche; Sanofi; Stemline Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen (Inst); Sanofi (Inst)
 
Chris Brawley
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Miguel Murillo
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Farrah Pompilus
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Jacqueline Egger
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Medical Research Council
 
Morrys Kaisermann
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Marek Hus
Honoraria - Abbvie; AstraZeneca; GlaxoSmithKline; Janssen; Sanofi; SOBI
Consulting or Advisory Role - AstraZeneca; Janssen; Novartis; SOBI